首页> 外国专利> Chimeric molecules FUSED to matrilin-1, Therapeutic use

Chimeric molecules FUSED to matrilin-1, Therapeutic use

机译:嵌合分子与matrilin-1融合,治疗用途

摘要

Chimeric molecules FUSED Peptide corresponding to the carboxyl end of Human matrilin-1 by a flexible Spacer, which gives them a longer Blood half-life and a higher specific activity for the non FUSED molecules.Claim 1: chimeric protein characterized in that essentially contains the carboxyl terminus of matrilin-1, identified in the list of Sequence as seq. Id.No: 19 from the amino acid Number 206 to 246, and a Protein Therapeutic, FUSED through a Spacer amino acid, which has a half-life and a higher specific activity than the Protein of Therapeutic use not merged.
机译:嵌合分子FUSED肽,通过柔性垫片与人matrilin-1的羧基末端相对应,从而使它们具有更长的血液半衰期和对非FUSED分子更高的比活性。权利要求1:嵌合蛋白,其特征在于基本上包含matrilin-1的羧基末端,在序列列表中标识为seq.。 Id。No:19(第206至246位氨基酸)和蛋白质治疗剂(FUSED)通过一个间隔氨基酸,其半衰期和比未合并的Therapeutic使用蛋白质更高的比活性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号